A study to evaluate the safety and efficacy of rilonacept in patients with deficiency of interleukin-1 receptor antagonist.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2015
At a glance
- Drugs Rilonacept (Primary)
- Indications Cryopyrin-associated periodic syndromes
- Focus Therapeutic Use
- 28 Aug 2015 New trial record